echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > France's Unitel Pharmaceuticals has launched the acquisition of Nanjing Reen Best Pharmaceutical Co., Ltd.

    France's Unitel Pharmaceuticals has launched the acquisition of Nanjing Reen Best Pharmaceutical Co., Ltd.

    • Last Update: 2020-09-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Read: Through Best's acquisition, Uniter will strengthen its growth in China, the world's second-largest pharmaceutical market.
    , August 25, 2020, Paris, France, Jiangsu, China: The global leader in sterile single-dose preparations, France's Unitel Pharmaceuticals launched the acquisition of Chinese pharmaceutical company Nanjing Renian Best Pharmaceutical Co., Ltd.
    acquisition of Best, Uniter will strengthen its growth in China, the world's second-largest pharmaceutical market, and complement its industrial base outside Europe, the United States and Brazil.
    Goupil, chief executive of Unitel, explained: "We are delighted to welcome this new company to the Unitel Group, which will enable us to conduct processing operations in China.
    this is in line with our strategy of producing close to the final market.
    acquisition, Unitel will provide services to local and multinational pharmaceutical companies developing the ophthalmology and respiratory markets in China, producing sterile, preservative-free single-dose preparations in China.
    About Nanjing Renian Best Pharmaceutical Co., Ltd. Nanjing Renian Best Pharmaceutical Co., Ltd. is a pharmaceutical company located in Nanjing City, Jiangsu Province, focusing on solid and liquid preparation production, turnover of 10 million euros, with 130 employees.
    an important asset of Wuxi Jinyuan Industrial Investment and Development Group Co., Ltd., a government investment platform belonging to Wuxi Binhu District.
    about Younitel Pharmaceuticals Group was founded in 1993 through the acquisition of a 17-employee plant in Amiens, France.
    is now a global leader in pharmaceutical manufacturing, producing sterile single-dose preparations and strip bagged preparations, including eye drops, nasal care fluids and atomized inhalation drugs, for original and generic customers.
    group has six production sites and an innovation research and development center in France, the United States and Brazil, with a turnover of 319 million euros in 2019.
    Group currently has more than 1,500 employees and continues to strengthen its global leadership in the production of blow-sealed sterile preparations.
    March 2017, Unitel Completed its fourth capital acquisition, which was acquired by Ardian, Keensight Capital, and Park capital from former shareholder Equistone Partners Europe and management.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.